2005
DOI: 10.1590/s0074-02762005000700003
|View full text |Cite
|
Sign up to set email alerts
|

Infection by Mycobacterium leprae of household contacts of lepromatous leprosy patients from a post-elimination leprosy region of Colombia

Abstract: The Leprosy Control Program of Antioquia, (post-elimination leprosy state of Colombia), had registered by 1999, 56 lepromatous leprosy patients and their household contacts (HHC). Our interest was to detect Mycobacterium leprae infection in these HHC. Clinical examination, acid-fast bacillary staining (AFB) in nasal secretions, and slit skin samples, IgM anti-PGL-I in serum and negative. These results are an indication that the transmission of the infection is still happening in a region considered in the pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
10
1
4

Year Published

2006
2006
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 9 publications
(12 reference statements)
1
10
1
4
Order By: Relevance
“…This is evident in the variation reported for different geographical populations. The current results show 13.4% (n = 54) of HHC with positive titers for IgM anti-PGL1; other studies have shown frequencies of infected contacts ranging from 13 to 93% (Meeker et al 1986, Amezcua et al 1987, Mora et al 1992, Cardona-Castro et al 2005. Nevertheless, this number of seropositive HHC does not indicate the true frequency of infected individuals in the studied population since some infected persons do not produce specific antibodies (Oskam et al 2003).…”
Section: Discussioncontrasting
confidence: 54%
See 1 more Smart Citation
“…This is evident in the variation reported for different geographical populations. The current results show 13.4% (n = 54) of HHC with positive titers for IgM anti-PGL1; other studies have shown frequencies of infected contacts ranging from 13 to 93% (Meeker et al 1986, Amezcua et al 1987, Mora et al 1992, Cardona-Castro et al 2005. Nevertheless, this number of seropositive HHC does not indicate the true frequency of infected individuals in the studied population since some infected persons do not produce specific antibodies (Oskam et al 2003).…”
Section: Discussioncontrasting
confidence: 54%
“…In a similar study designed to detect Mycobacterium leprae infection in HHC in a non-prevalent region of Colombia, we found two HHC with multibacillary leprosy (Cardona-Castro et al 2005). These findings suggest that early diagnosis of leprosy in HHC through clinical examination at the time of index case diagnosis is not sufficient and that continued follow-up and testing using other available diagnostic tools is necessary.…”
mentioning
confidence: 76%
“…It is important to note that one of the HHC who sero-converted was an 11-year-old girl, which demonstrates the importance of follow-up of M. leprae infection in children for early disease detection and disability prevention in a young population. Other studies have shown frequencies of infected contacts that range from 13-93% (Meeker et al 1986, Amezcua et al 1987, Cardona-Castro et al 2005. Early detection of PB leprosy was possible in one HHC who had a unique lesion and the diagnosis was confirmed by positive nested PCR.…”
mentioning
confidence: 86%
“…Therefore, diagnosis is often delayed, contributing to the onset of the disease and allowing transmission and sequelae (Lockwood & Kumar 2004). The use of other tests in addition to periodic evaluations by clinical exam to detect infected HHC, as well as detailing their immune response and bacteriological state, can contribute to the identification of infected HHC and new leprosy cases (Cardona-Castro et al 2005).…”
mentioning
confidence: 99%
“…Indeed, studies have shown that contacts of MB leprosy patients have an increased risk of developing leprosy themselves (41). It has also been found that contacts who have an antibody response to the M. lepraespecific phenolic glycolipid (phenolic glycolipid I [PGL-I]) have a much greater chance to develop clinical leprosy than those without an antibody response (3,7,19,23). Yet almost half of those who have antibodies to PGL-I never develop leprosy, and half of those who develop leprosy never have PGL-I antibody.…”
mentioning
confidence: 99%